Aditxt amends Evofem merger terms, reduces third investment to $720k; effectuates 1-for-40 reverse stock split

Aditxt, Inc.

Amendment No. 3 to Evofem merger: Third investment reduced from $1.5M to $720k, due Oct 2; Fourth increased from $1.5M to $2.28M, due Oct 31.
1-for-40 reverse stock split effective Oct 1, 2024; trading on split-adjusted basis from Oct 2.
On Oct 2, 2024, Aditxt purchased 720 shares of Evofem Series F-1 Preferred for $720k under amended terms.
Evofem waived Aditxt's prior non-compliance with Parent Equity Investment obligations.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Aditxt, Inc.: Certificate of incorporation amended to effect a one-for-forty reverse stock split of common stock (effective 2024-10-01).

Change: charter amendment
Effective: 2024-10-01

Exact text from the filing

On October 1, 2024, the Company filed with the Secretary of State of the State of Delaware a certificate of amendment to its certificate of incorporation (the “Certificate of Amendment”) to effect the Reverse Stock Split.

View on SEC.gov

89 governance changes filed in the last 30 days. Browse all governance changes →

Aditxt, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-24-085056

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.